home / stock / bmra / bmra news


BMRA News and Press, Biomerica Inc. From 12/16/21

Stock Information

Company Name: Biomerica Inc.
Stock Symbol: BMRA
Market: NASDAQ
Website: biomerica.com

Menu

BMRA BMRA Quote BMRA Short BMRA News BMRA Articles BMRA Message Board
Get BMRA Alerts

News, Short Squeeze, Breakout and More Instantly...

BMRA - Biomercia rallies after sailing past Q2 revenue estimates: Prelim

Biomercia (NASDAQ:BMRA) is up 12% in pre-market trading after the company reported 238% revenue growth in its Q2 preliminary earnings report. Revenue made a easy beat at $4.6M (+238% Y/Y), compared to the market consensus of $1.81M. The increase reflects the surge in demand for Covi...

BMRA - AGEN, LYG and ARVL among pre market gainers

Calliditas Therapeutics (NASDAQ:CALT) +38% on FDA approval for kidney disease therapy. Kaixin Auto (NASDAQ:KXIN) +27% on a partnership agreement with Bujia for 10k new energy trucks. Biomerica (NASDAQ:BMRA) +18% preliminary second quarter revenue increase of approxima...

BMRA - Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million

InFoods ® IBS Clinical Trial on Track for Completion in December with Topline Results Expected to be Announced in January, 2022. IRVINE, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced certain prelimin...

BMRA - Biomerica Forms Scientific Advisory Board for Colorectal Cancer Screening

Chaired by Dr. Brooks Cash, Chief of Gastroenterology and Hepatology at the University of Texas Health Center at Houston Scientific Advisory Board to guide on programs to screen and test patients in US and other countries where colorectal cancer screening is limited due to c...

BMRA - Biomerica gets notice of allowance for new patent in Canada

Biomerica (NASDAQ:BMRA) announces that the Canadian Patent Office has issued a notice of allowance for the company's patent application related to its InFoods diagnostic guided therapy platform technology. The technology offers a novel approach in the treatment of patients suffering from...

BMRA - Biomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS) Food Sensitivity Testing & Treatment

Studies show that 13-20% of Canadians suffer from IBS at any given time 1 . The lifetime risk for a Canadian to develop IBS is 30% 1 . IRVINE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA ) today announced that...

BMRA - Biomerica Launches New Website for Its Aware® Breast Exam Device

Simple at-home breast exam device provides results within minutes Studies show increase in Breast Exam Sensitivity IRVINE, Calif. , Oct. 29, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that in conjunction with...

BMRA - AG, FRO and WATT among pre market gainers

Energous (NASDAQ:WATT) +35% granted FCC approval for unlimited Distance over-the-air wireless charging Edesa Biotech (NASDAQ:EDSA) +29% reports favorable mortality reductions in COVID-19 study InflaRx (NASDAQ:IFRX) +21% after EUR 43.7M vilobelimab development grant En...

BMRA - Walmart to Begin Nationwide In-Store Sales of Biomerica's EZ Detect(TM) Colorectal Screening Test

Over 4,600 Walmart Stores to sell the EZ Detect ™ product Simple 2 minute at-home test detects early warning sign of colorectal cancer IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announce...

BMRA - Biomerica Reports Results for Fiscal First Quarter ended August 31, 2021

Revenues up 10% over fiscal first quarter 2021, and 20% over fiscal fourth quarter 2021 Customer orders backlog of over $1.5 million at August 31, 2021 Following close of first fiscal quarter 2022, Walmart began online sales of Biomerica’s EZ Detect™ ...

Previous 10 Next 10